Michael R Abern | Scholars@Duke

Michael R Abern
Associate Professor of Surgery

Current Research Interests

Biomarkers of prostate cancer
Quantitative imaging of genitorurinary cancers
Surgical innovation

Current Appointments & Affiliations

Associate Professor of Surgery, Surgery, Urology, Surgery 2022
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2021

Contact Information

200 Trent Drive, DUMC Box 2804, Durham, NC 27710
40 Duke Medicine Circle, DUMC Box 3707, Durham, NC 27710
michael.abern@duke.edu (919) 684-5707

Background
Education, Training, & Certifications
- Urologic Oncology Fellow, Surgery, Duke University School of Medicine 2011 - 2013
- Urology Resident, Surgery, Rush University Medical Center 2006 - 2011
- M.D., Rush University, Medical College 2006
- B.S., University of Illinois 1996
Previous Appointments & Affiliations
- Instructor in the Department of Surgery, Surgery, Urology, Surgery 2021 - 2022
- Clinical Associate in the Department of Surgery, Surgery, Urology, Surgery 2011 - 2013
Expertise
Subject Headings
Research
Selected Grants
- Medtronic Expand URO - Pro00108661 awarded by Medtronic, Inc. 2021 - 2026
External Relationships
- Medtronic
- Veru Inc.
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Francavilla, Simone, Michael R. Abern, Ryan W. Dobbs, Hari T. Vigneswaran, Susan Talamini, Alessandro Antonelli, Claudio Simeone, and Simone Crivellaro. “Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port platform (IDEAL Phase 1).” Minerva Urol Nephrol 74, no. 2 (April 2022): 216–24. https://doi.org/10.23736/S2724-6051.21.03919-9.
    Full Text Link to Item
  - Reiter, Rolf, Shreyan Majumdar, Steven Kearney, André Kajdacsy-Balla, Virgilia Macias, Simone Crivellaro, Michael Abern, Thomas J. Royston, and Dieter Klatt. “Investigating the heterogeneity of viscoelastic properties in prostate cancer using MR elastography at 9.4T in fresh prostatectomy specimens.” Magn Reson Imaging 87 (April 2022): 113–18. https://doi.org/10.1016/j.mri.2022.01.005.
    Full Text Link to Item
  - Del Pino, Matthew, Michael R. Abern, and Daniel M. Moreira. “Prostate Cancer Disparities in Hispanics Using the National Cancer Database.” Urology, March 26, 2022. https://doi.org/10.1016/j.urology.2022.02.025.
    Full Text Link to Item
  - Murphy, A. B., M. R. Abern, L. Liu, H. Wang, C. M. P. Hollowell, R. Sharifi, P. Vidal, et al. “Re: Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population with Favorable-Risk Prostate Cancer: A Randomized Trial.” Journal of Urology 206, no. 6 (December 2021): 1507–8.
    Link to Item
  - Vigneswaran, Hari T., Jyotsna S. Jagai, David T. Greenwald, Achal P. Patel, Megh Kumar, Ryan W. Dobbs, Daniel M. Moreira, and Michael R. Abern. “Association between environmental quality and prostate cancer stage at diagnosis.” Prostate Cancer Prostatic Dis 24, no. 4 (December 2021): 1129–36. https://doi.org/10.1038/s41391-021-00370-z.
    Full Text Link to Item
  - Vijayakumar, Vishwaarth, Michael R. Abern, Jyotsna S. Jagai, and André Kajdacsy-Balla. “Observational Study of the Association between Air Cadmium Exposure and Prostate Cancer Aggressiveness at Diagnosis among a Nationwide Retrospective Cohort of 230,540 Patients in the United States.” Int J Environ Res Public Health 18, no. 16 (August 6, 2021). https://doi.org/10.3390/ijerph18168333.
    Full Text Link to Item
  - Hu, Wen-Yang, Dan-Ping Hu, Lishi Xie, Larisa Nonn, Ranli Lu, Michael Abern, Toshihiro Shioda, and Gail S. Prins. “Keratin Profiling by Single-Cell RNA-Sequencing Identifies Human Prostate Stem Cell Lineage Hierarchy and Cancer Stem-Like Cells.” Int J Mol Sci 22, no. 15 (July 28, 2021). https://doi.org/10.3390/ijms22158109.
    Full Text Link to Item
  - Vigneswaran, Hari T., Luke Mittelstaedt, Alessio Crippa, Martin Eklund, Adriana Vidal, Stephen J. Freedland, and Michael R. Abern. “Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis.” Prostate Cancer Prostatic Dis, July 8, 2021. https://doi.org/10.1038/s41391-021-00425-1.
    Full Text Link to Item
  - McCray, Tara, Julian V. Pacheco, Candice C. Loitz, Jason Garcia, Bethany Baumann, Michael J. Schlicht, Klara Valyi-Nagy, Michael R. Abern, and Larisa Nonn. “Erratum: Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids.” Iscience 24, no. 6 (June 25, 2021): 102640. https://doi.org/10.1016/j.isci.2021.102640.
    Full Text Link to Item
  - Naha, Ushasi, Stephen J. Freedland, Michael R. Abern, and Daniel M. Moreira. “The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer.” Prostate Cancer Prostatic Dis 24, no. 2 (June 2021): 335–40. https://doi.org/10.1038/s41391-020-00279-z.
    Full Text Link to Item
  - Murphy, Adam B., Michael R. Abern, Li Liu, Heidy Wang, Courtney M. P. Hollowell, Roohollah Sharifi, Patricia Vidal, et al. “Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.” J Clin Oncol 39, no. 15 (May 20, 2021): 1660–70. https://doi.org/10.1200/JCO.20.02997.
    Full Text Link to Item
  - Vigneswaran, Hari T., Logan S. Schwarzman, Ikenna C. Madueke, Shannon MacLaughlan David, Johan Nordenstam, Daniel Moreira, and Michael R. Abern. “Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US.” Ann Surg Oncol 28, no. 5 (May 2021): 2790–2800. https://doi.org/10.1245/s10434-020-09247-2.
    Full Text Link to Item
  - Vigneswaran, Hari T., Andrea Discacciati, Peter H. Gann, Henrik Grönberg, Martin Eklund, and Michael R. Abern. “Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort.” Prostate Cancer Prostatic Dis 24, no. 1 (March 2021): 120–27. https://doi.org/10.1038/s41391-020-0250-2.
    Full Text Link to Item
  - McCray, Tara, Julian V. Pacheco, Candice C. Loitz, Jason Garcia, Bethany Baumann, Michael J. Schlicht, Klara Valyi-Nagy, Michael R. Abern, and Larisa Nonn. “Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids.” Iscience 24, no. 1 (January 22, 2021): 101974. https://doi.org/10.1016/j.isci.2020.101974.
    Full Text Link to Item
  - Vigneswaran, Hari, and Michael Abern. “EDITORIAL COMMENT.” Urology 147 (January 2021): 221–22. https://doi.org/10.1016/j.urology.2020.07.069.
    Full Text Link to Item
  - Reiter, Rolf, Shreyan Majumdar, Steven Kearney, Andre Kajdacsy-Balla, Virgilia Macias, Simone Crivellaro, Brandon Caldwell, Michael Abern, Thomas J. Royston, and Dieter Klatt. “Prostate cancer assessment using MR elastography of fresh prostatectomy specimens at 9.4 T.” Magn Reson Med 84, no. 1 (July 2020): 396–404. https://doi.org/10.1002/mrm.28127.
    Full Text Link to Item
  - Kaouk, Jihad, Alireza Aminsharifi, Clark A. Wilson, Guilherme Sawczyn, Juan Garisto, Simone Francavilla, Michael Abern, and Simone Crivellaro. “Extraperitoneal versus Transperitoneal Single Port Robotic Radical Prostatectomy: A Comparative Analysis of Perioperative Outcomes.” J Urol 203, no. 6 (June 2020): 1135–40. https://doi.org/10.1097/JU.0000000000000700.
    Full Text Link to Item
  - Dobbs, Ryan W., James Stinson, Shaleen R. Vasavada, Brandon M. Caldwell, Vincent L. Freeman, Daniel F. Garvey, Jack Lu, Daniel M. Moreira, and Michael R. Abern. “Helping Men Find Their Way: Improving Prostate Cancer Clinic Attendance via Patient Navigation.” J Community Health 45, no. 3 (June 2020): 561–68. https://doi.org/10.1007/s10900-019-00776-w.
    Full Text Link to Item
  - Jones, Rabun, Ryan W. Dobbs, Whitney R. Halgrimson, Hari T. Vigneswaran, Ikenna Madueke, Jessica Wilson, Michael R. Abern, and Simone Crivellaro. “Single port robotic radical prostatectomy with the da Vinci SP platform: a step by step approach.” Can J Urol 27, no. 3 (June 2020): 10263–69.
    Link to Item
  - Vigneswaran, Hari T., Logan S. Schwarzman, Simone Francavilla, Michael R. Abern, and Simone Crivellaro. “A Comparison of Perioperative Outcomes Between Single-port and Multiport Robot-assisted Laparoscopic Prostatectomy.” Eur Urol 77, no. 6 (June 2020): 671–74. https://doi.org/10.1016/j.eururo.2020.03.031.
    Full Text Link to Item
  - Morgantini, Luca A., Ushasi Naha, Heng Wang, Simone Francavilla, Ömer Acar, Jose M. Flores, Simone Crivellaro, et al. “Factors Contributing to Healthcare Professional Burnout During the COVID-19 Pandemic: A Rapid Turnaround Global Survey.” Medrxiv, May 22, 2020. https://doi.org/10.1101/2020.05.17.20101915.
    Full Text Link to Item
  - Watson, Karriem, Joanna Buscemi, Marian Fitzgibbon, Marcus Murray, Adam Murphy, Michael Abern, Peter Gann, et al. “Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men.” Transl Behav Med 10, no. 2 (May 20, 2020): 492–94. https://doi.org/10.1093/tbm/ibz034.
    Full Text Link to Item
  - Schwarzman, Logan S., Rodrigo L. Pagani, Samuel J. Ohlander, Mahmoud Mima, Michael R. Abern, Gerald L. Andriole, Stephen J. Freedland, and Daniel M. Moreira. “Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy.” Urology 137 (March 2020): 97–101. https://doi.org/10.1016/j.urology.2019.11.004.
    Full Text Link to Item
  - Morgantini, Luca A., Ushasi Naha, Heng Wang, Simone Francavilla, Ömer Acar, Jose M. Flores, Simone Crivellaro, et al. “Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey.” Plos One 15, no. 9 (2020): e0238217. https://doi.org/10.1371/journal.pone.0238217.
    Full Text Link to Item
  - Setia, Shaan, Carol Feng, Christopher Coogan, Srinivas Vourganti, and Michael Abern. “Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop.” Urology 134 (December 2019): 51–55. https://doi.org/10.1016/j.urology.2019.09.004.
    Full Text Link to Item
  - Madueke, Ikenna, Wen-Yang Hu, Danping Hu, Steven M. Swanson, Donald Vander Griend, Michael Abern, and Gail S. Prins. “The role of WNT10B in normal prostate gland development and prostate cancer.” Prostate 79, no. 14 (October 2019): 1692–1704. https://doi.org/10.1002/pros.23894.
    Full Text Link to Item
  - Madueke, Ikenna, and Michael R. Abern. “Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?” Oncology (Williston Park) 33, no. 6 (June 19, 2019): 235–42.
    Link to Item
  - Bhat, Abhishek, and Sanoj Punnen. “Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?” Oncology (Williston Park) 33, no. 6 (June 19, 2019): 235–36.
    Link to Item
  - Dobbs, Ryan W., Neha R. Malhotra, David T. Greenwald, Alice Y. Wang, Gail S. Prins, and Michael R. Abern. “Estrogens and prostate cancer.” Prostate Cancer Prostatic Dis 22, no. 2 (May 2019): 185–94. https://doi.org/10.1038/s41391-018-0081-6.
    Full Text Link to Item
  - Tan, Wei Phin, Dimitri Papagiannopoulos, Kalyan C. Latchamsetty, Nathaniel Wilson, Nicholas O’Block, Lester Raff, Alfredo Mena Lora, Christopher L. Coogan, and Michael R. Abern. “Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.” Prostate Cancer Prostatic Dis 22, no. 2 (May 2019): 268–75. https://doi.org/10.1038/s41391-018-0092-3.
    Full Text Link to Item
  - Tan, Wei Phin, Dimitri Papagiannopoulos, Kalyan C. Latchamsetty, Nathaniel Wilson, Nicholas O’Block, Lester Raff, Alfredo Mena Lora, Christopher L. Coogan, and Michael R. Abern. “Correction: Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.” Prostate Cancer Prostatic Dis 22, no. 2 (May 2019): 350. https://doi.org/10.1038/s41391-019-0133-6.
    Full Text Link to Item
  - Dobbs, Ryan W., Neha R. Malhotra, Michael R. Abern, and Daniel M. Moreira. “Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis.” Prostate Cancer Prostatic Dis 22, no. 1 (March 2019): 159–67. https://doi.org/10.1038/s41391-018-0097-y.
    Full Text Link to Item
  - Caldwell, Brandon, David Greenwald, Daniel Moreira, Rong-Wen Tain, Christopher Coogan, Karen Xie, Winnie Mar, Peter Pfanner, and Michael Abern. “Constructing and Pilot Testing a Novel Prostate Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Phantom.” Urology 124 (February 2019): 33–37. https://doi.org/10.1016/j.urology.2018.10.029.
    Full Text Link to Item
  - Schwarzman, Logan S., Michael R. Abern, Daniel F. Garvey, Gerald L. Andriole, Stephen J. Freedland, and Daniel M. Moreira. “The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy Scheme.” J Urol 200, no. 5 (November 2018): 1062–67. https://doi.org/10.1016/j.juro.2018.06.018.
    Full Text Link to Item
  - Tsivian, Matvey, Michael R. Abern, Efrat Tsivian, Christina Sze, Ghalib Jibara, Edward N. Rampersaud, and Thomas J. Polascik. “Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.” Urol Oncol 36, no. 8 (August 2018): 362.e1-362.e7. https://doi.org/10.1016/j.urolonc.2018.04.014.
    Full Text Link to Item
  - Vasavada, Shaleen R., Ryan W. Dobbs, André A. Kajdacsy-Balla, Michael R. Abern, and Daniel M. Moreira. “Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis.” J Urol 199, no. 5 (May 2018): 1174–81. https://doi.org/10.1016/j.juro.2017.11.120.
    Full Text Link to Item
  - Dobbs, Ryan W., and Michael R. Abern. “A novel bladder cancer urinary biomarker: can it go where no marker has gone before?” Transl Androl Urol 7, no. Suppl 1 (March 2018): S96–97. https://doi.org/10.21037/tau.2018.01.04.
    Full Text Link to Item
  - Dobbs, Ryan W., Neha R. Malhotra, Brandon M. Caldwell, Raymond Rojas, Daniel M. Moreira, and Michael R. Abern. “Determinants of Clinic Absenteeism: A Novel Method of Examining Distance from Clinic and Transportation.” J Community Health 43, no. 1 (February 2018): 19–26. https://doi.org/10.1007/s10900-017-0382-z.
    Full Text Link to Item
  - Papagiannopoulos, Dimitri, Michael Abern, Nathaniel Wilson, Nicholas O’Block, Lester Raff, Christopher Coogan, and Kalyan C. Latchamsetty. “Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.” J Urol 199, no. 1 (January 2018): 155–60. https://doi.org/10.1016/j.juro.2017.08.040.
    Full Text Link to Item
  - Chow, Alexander K., Benjamin A. Sherer, Emily Yura, Stephanie Kielb, Ervin Kocjancic, Scott Eggener, Thomas Turk, et al. “Urology Residents' Experience and Attitude Toward Surgical Simulation: Presenting our 4-Year Experience With a Multi-institutional, Multi-modality Simulation Model.” Urology 109 (November 2017): 32–37. https://doi.org/10.1016/j.urology.2017.05.037.
    Full Text Link to Item
  - Abhyankar, Nikita, Kent F. Hoskins, Michael R. Abern, and Gregory S. Calip. “Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.” Bmc Cancer 17, no. 1 (September 25, 2017): 659. https://doi.org/10.1186/s12885-017-3640-7.
    Full Text Link to Item
  - Malhotra, Neha R., Carlos Amir Esparza Monzavi, Jean-Sebastien Trepanier, Johan Nordenstam, and Michael R. Abern. “Biliary Stent Migration: A Rare Cause of a Bladder Stone.” Urology 104 (June 2017): e1–2. https://doi.org/10.1016/j.urology.2017.03.007.
    Full Text Link to Item
  - Dobbs, R. W., D. T. Greenwald, H. Wadhwa, V. L. Freeman, and M. R. Abern. “Is prostate cancer stage migration continuing for black men in the PSA era?” Prostate Cancer Prostatic Dis 20, no. 2 (June 2017): 210–15. https://doi.org/10.1038/pcan.2016.68.
    Full Text Link to Item
  - Sharif, Asma, Neha R. Malhotra, Andres M. Acosta, Andre A. Kajdacsy-Balla, Maarten Bosland, Grace Guzman, Gail S. Prins, and Michael R. Abern. “The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?” Prostate 77, no. 8 (June 2017): 824–28. https://doi.org/10.1002/pros.23322.
    Full Text Link to Item
  - Tsivian, Matvey, Rajan T. Gupta, Efrat Tsivian, Peter Qi, Melissa H. Mendez, Michael R. Abern, Kae Jack Tay, and Thomas J. Polascik. “Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.” Int J Urol 24, no. 2 (February 2017): 137–43. https://doi.org/10.1111/iju.13251.
    Full Text Link to Item
  - Fantony, Joseph J., Thomas A. Longo, Ajay Gopalakrishna, Richmond Owusu, Raymond S. Lance, Wen-Chi Foo, Brant A. Inman, and Michael R. Abern. “Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.” Cancer Biomark 18, no. 4 (2017): 381–87. https://doi.org/10.3233/CBM-160261.
    Full Text Link to Item
  - Wadhwa, H., M. K. Terris, W. J. Aronson, C. J. Kane, C. L. Amling, M. R. Cooperberg, S. J. Freedland, and M. R. Abern. “Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.” Prostate Cancer Prostatic Dis 19, no. 4 (December 2016): 423–28. https://doi.org/10.1038/pcan.2016.45.
    Full Text Link to Item
  - Fantony, Joseph J., Michael R. Abern, Ajay Gopalakrishna, Richmond Owusu, Kae Jack Tay, Raymond S. Lance, and Brant A. Inman. “Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.” Urol Oncol 33, no. 9 (September 2015): 387.e1-387.e6. https://doi.org/10.1016/j.urolonc.2015.04.014.
    Full Text Link to Item
  - Ovadia, Aaron, and Michael Abern. “Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?” Eur Urol 68, no. 1 (July 2015): 40–41. https://doi.org/10.1016/j.eururo.2014.10.046.
    Full Text Link to Item
  - Sun, Belinda L., Michael Abern, Steven Garzon, and Suman Setty. “Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrence.” Int J Surg Pathol 23, no. 3 (May 2015): 238–42. https://doi.org/10.1177/1066896914563391.
    Full Text Link to Item
  - Wang, Hsin-Hsiao S., Michael R. Abern, Nicholas G. Cost, David I. Chu, Sherry S. Ross, John S. Wiener, and Jonathan C. Routh. “Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.” J Urol 192, no. 4 (October 2014): 1196–1202. https://doi.org/10.1016/j.juro.2014.04.003.
    Full Text Link to Item
  - Qi, Peter, Matvey Tsivian, Michael R. Abern, Niccolo M. Passoni, Kathleen F. McGinley, and Thomas J. Polascik. “Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.” Urol Oncol 32, no. 5 (July 2014): 555–60. https://doi.org/10.1016/j.urolonc.2013.11.011.
    Full Text Link to Item
  - Abern, Michael R., Martha K. Terris, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, and Stephen J. Freedland. “The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer.” Cancer 120, no. 11 (June 1, 2014): 1656–62. https://doi.org/10.1002/cncr.28647.
    Full Text Link to Item
  - Abern, Michael R., Emelian Scosyrev, Matvey Tsivian, Edward M. Messing, Thomas J. Polascik, and Arkadiusz Z. Dudek. “Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era.” Anticancer Res 34, no. 5 (May 2014): 2405–11.
    Link to Item
  - Abern, Michael R., Richmond Owusu, and Brant A. Inman. “Clinical performance and utility of a DNA methylation urine test for bladder cancer.” Urol Oncol 32, no. 1 (January 2014): 51.e21-51.e26. https://doi.org/10.1016/j.urolonc.2013.08.003.
    Full Text Link to Item
  - Allott, E. H., M. R. Abern, L. Gerber, C. J. Keto, W. J. Aronson, M. K. Terris, C. J. Kane, et al. “Metformin does not affect risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database.” Prostate Cancer and Prostatic Diseases 16, no. 4 (December 1, 2013): 391–97. https://doi.org/10.1038/pcan.2013.48.
    Full Text
  - Allott, E. H., M. R. Abern, L. Gerber, C. J. Keto, W. J. Aronson, M. K. Terris, C. J. Kane, et al. “Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.” Prostate Cancer Prostatic Dis 16, no. 4 (December 2013): 391–97. https://doi.org/10.1038/pcan.2013.48.
    Full Text Link to Item
  - Abern, Michael R., Annie M. Dude, Matvey Tsivian, and Christopher L. Coogan. “The characteristics of bladder cancer after radiotherapy for prostate cancer.” Urol Oncol 31, no. 8 (November 2013): 1628–34. https://doi.org/10.1016/j.urolonc.2012.04.006.
    Full Text Link to Item
  - Abern, Michael R., Matvey Tsivian, Christopher L. Coogan, Howard L. Kaufman, and Thomas J. Polascik. “Characteristics of patients diagnosed with both melanoma and renal cell cancer.” Cancer Causes Control 24, no. 11 (November 2013): 1925–33. https://doi.org/10.1007/s10552-013-0267-0.
    Full Text Link to Item
  - Qi, Peter, Matvey Tsivian, Michael R. Abern, Lionel L. Bañez, Ping Tang, Judd W. Moul, and Thomas J. Polascik. “Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml.” Urol Oncol 31, no. 8 (November 2013): 1527–32. https://doi.org/10.1016/j.urolonc.2012.06.003.
    Full Text Link to Item
  - Ross, Sherry S., Elizabeth M. Masko, Michael R. Abern, Emma H. Allott, Jonathan C. Routh, John S. Wiener, Glenn M. Preminger, Stephen J. Freedland, and Michael E. Lipkin. “The effect of dietary sodium and fructose intake on urine and serum parameters of stone formation in a pediatric mouse model: a pilot study.” J Urol 190, no. 4 Suppl (October 2013): 1484–89. https://doi.org/10.1016/j.juro.2013.02.3199.
    Full Text Link to Item
  - Tsivian, Matvey, Michael R. Abern, John J. Yoo, Paul Evans, Peter Qi, Charles Y. Kim, Michael E. Lipkin, Thomas J. Polascik, and Michael N. Ferrandino. “Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics.” J Endourol 27, no. 9 (September 2013): 1102–6. https://doi.org/10.1089/end.2013.0111.
    Full Text Link to Item
  - Tsivian, Matvey, Michael R. Abern, Peter Qi, and Thomas J. Polascik. “Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy.” Urology 82, no. 1 (July 2013): 166–70. https://doi.org/10.1016/j.urology.2013.01.071.
    Full Text Link to Item
  - Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Refining treatment for the men who need it: lessons from the PIVOT trial.” Transl Androl Urol 2, no. 2 (June 2013): 82–84. https://doi.org/10.3978/j.issn.2223-4683.2012.09.05.
    Full Text Link to Item
  - Abern, Michael R., Richmond A. Owusu, Mark R. Anderson, Edward N. Rampersaud, and Brant A. Inman. “Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.” J Natl Compr Canc Netw 11, no. 4 (April 1, 2013): 477–84. https://doi.org/10.6004/jnccn.2013.0060.
    Full Text Link to Item
  - Abern, Michael R., William J. Aronson, Martha K. Terris, Christopher J. Kane, Joseph C. Presti, Christopher L. Amling, and Stephen J. Freedland. “Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.” Prostate 73, no. 4 (March 2013): 409–17. https://doi.org/10.1002/pros.22582.
    Full Text Link to Item
  - Benson, Jonas S., Michael R. Abern, Stephen Larsen, and Laurence A. Levine. “Does a positive response to spermatic cord block predict response to microdenervation of the spermatic cord for chronic scrotal content pain?” J Sex Med 10, no. 3 (March 2013): 876–82. https://doi.org/10.1111/j.1743-6109.2012.02937.x.
    Full Text Link to Item
  - Abern, M. R., M. R. Bassett, M. Tsivian, L. L. Bañez, T. J. Polascik, M. N. Ferrandino, C. N. Robertson, S. J. Freedland, and J. W. Moul. “Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center.” Prostate Cancer Prostatic Dis 16, no. 1 (March 2013): 85–90. https://doi.org/10.1038/pcan.2012.38.
    Full Text Link to Item
  - Abern, M. R., M. R. Bassett, M. Tsivian, L. L. Bañez, T. J. Polascik, M. N. Ferrandino, C. N. Robertson, S. J. Freedland, and J. W. Moul. “Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center.” Prostate Cancer and Prostatic Diseases 16, no. 1 (March 1, 2013): 85–90.
  - Tsivian, M., L. L. Bañez, C. J. Keto, M. R. Abern, P. Qi, L. Gerber, J. W. Moul, and T. J. Polascik. “African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.” Prostate Cancer Prostatic Dis 16, no. 1 (March 2013): 91–94. https://doi.org/10.1038/pcan.2012.39.
    Full Text Link to Item
  - Tsivian, M., L. L. Bañez, C. J. Keto, M. R. Abern, P. Qi, L. Gerber, J. W. Moul, and T. J. Polascik. “African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.” Prostate Cancer and Prostatic Diseases 16, no. 1 (March 1, 2013): 91–94.
  - Abern, Michael R., and Stephen J. Freedland. “Prostate cancer antigen 3 to select men for prostate biopsy: stop, go, or proceed with caution?” Eur Urol 63, no. 2 (February 2013): 210–11. https://doi.org/10.1016/j.eururo.2012.09.002.
    Full Text Link to Item
  - Tsivian, M., M. R. Abern, and T. J. Polascik. “Evolution of the concept of focal therapy for prostate cancer.” Oncology (Williston Park, N.Y.) 27, no. 1 (January 1, 2013).
  - Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Evolution of the concept of focal therapy for prostate cancer.” Oncology (Williston Park) 27, no. 1 (January 2013): 64–70.
    Link to Item
  - Owusu, Richmond A., Michael R. Abern, and Brant A. Inman. “Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer.” Biomed Res Int 2013 (2013): 262313. https://doi.org/10.1155/2013/262313.
    Full Text Link to Item
  - Abern, Michael R., Emma H. Allott, and Stephen J. Freedland. “C-reactive protein as a prognostic marker FOR mCRPC.” Bju Int 110, no. 11 Pt B (December 2012): E469. https://doi.org/10.1111/j.1464-410X.2012.11156.x.
    Full Text Link to Item
  - Tsivian, Matvey, Said Ulusoy, Michael Abern, Ayelet Wandel, A Ami Sidi, and Alexander Tsivian. “Renal mass anatomic characteristics and perioperative outcomes of laparoscopic partial nephrectomy: a critical analysis.” J Endourol 26, no. 10 (October 2012): 1307–13. https://doi.org/10.1089/end.2012.0148.
    Full Text Link to Item
  - Abern, Michael R., Annie M. Dude, and Christopher L. Coogan. “Marital status independently predicts testis cancer survival--an analysis of the SEER database.” Urol Oncol 30, no. 4 (July 2012): 487–93. https://doi.org/10.1016/j.urolonc.2010.03.005.
    Full Text Link to Item
  - Abern, Michael R., Matvey Tsivian, Thomas J. Polascik, and Christopher L. Coogan. “Characteristics and outcomes of tumors arising from the distal nephron.” Urology 80, no. 1 (July 2012): 140–46. https://doi.org/10.1016/j.urology.2012.03.034.
    Full Text Link to Item
  - Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.” Curr Urol Rep 13, no. 2 (April 2012): 160–69. https://doi.org/10.1007/s11934-012-0241-5.
    Full Text Link to Item
  - Abern, Michael R., Stephen Larsen, and Laurence A. Levine. “Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.” J Sex Med 9, no. 1 (January 2012): 288–95. https://doi.org/10.1111/j.1743-6109.2011.02519.x.
    Full Text Link to Item
  - Taylor, Frederick L., Michael R. Abern, and Laurence A. Levine. “Predicting erectile dysfunction following surgical correction of Peyronie's disease without inflatable penile prosthesis placement: vascular assessment and preoperative risk factors.” J Sex Med 9, no. 1 (January 2012): 296–301. https://doi.org/10.1111/j.1743-6109.2011.02460.x.
    Full Text Link to Item
  - Abern, Michael, Howard L. Kaufman, and Kalyan Latchamsetty. “An update on TroVax for the treatment of progressive castration-resistant prostate cancer.” Onco Targets Ther 4 (2011): 33–41. https://doi.org/10.2147/OTT.S14271.
    Full Text Link to Item
  - Abern, Michael Ryan, Jonas Samuel Benson, and Jerome Hoeksema. “Ureteral mullerianosis.” J Endourol 23, no. 12 (December 2009): 1933–35. https://doi.org/10.1089/end.2009.0321.
    Full Text Link to Item
  - Benson, Jonas S., Michael R. Abern, and Laurence A. Levine. “Penile shortening after radical prostatectomy and Peyronie's surgery.” Curr Urol Rep 10, no. 6 (November 2009): 468–74. https://doi.org/10.1007/s11934-009-0074-z.
    Full Text Link to Item
  - Abern, Michael R., and Laurence A. Levine. “Ketoconazole and prednisone to prevent recurrent ischemic priapism.” J Urol 182, no. 4 (October 2009): 1401–6. https://doi.org/10.1016/j.juro.2009.06.040.
    Full Text Link to Item
  - Abern, Michael R., and Laurence A. Levine. “Peyronie's disease: evaluation and review of nonsurgical therapy.” Scientificworldjournal 9 (July 27, 2009): 665–75. https://doi.org/10.1100/tsw.2009.92.
    Full Text Link to Item
  - Levine, Laurence A., Michael R. Abern, and Matthew M. Lux. “Persistent motile sperm after ligation band vasectomy.” J Urol 176, no. 5 (November 2006): 2146–48. https://doi.org/10.1016/j.juro.2006.07.028.
    Full Text Link to Item
- Book Sections
  - Moreira, D. M., and M. R. Abern. “Prostate cancer: Overview, detection, treatment.” In Encyclopedia of Reproduction, 474–78, 2018. https://doi.org/10.1016/B978-0-12-801238-3.65168-1.
    Full Text
  - Vigneswaran, H. T., and M. Abern. “Testicular cancer.” In Encyclopedia of Reproduction, 479–83, 2018. https://doi.org/10.1016/B978-0-12-801238-3.64814-6.
    Full Text
  - Abern, M. R., M. Tsivian, and J. W. Moul. “Prostate cancer.” In Urology at a Glance, 201–5, 2014. https://doi.org/10.1007/978-3-642-54859-8_40.
    Full Text
- Other Articles
  - Inman, Brant A., and Michael R. Abern. “Maintenance bacillus Calmette-Guérin: why is there continued debate?” Eur Urol, October 2013. https://doi.org/10.1016/j.eururo.2013.05.055.
    Full Text Link to Item
  - Inman, Brant A., and Michael R. Abern. “Interpreting a study on bladder cancer screening.” Eur Urol, July 2013. https://doi.org/10.1016/j.eururo.2013.03.047.
    Full Text Link to Item
  - Abern, Michael R., Stephen J. Freedland, and Brant A. Inman. “Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.” Bju Int, February 2013. https://doi.org/10.1111/j.1464-410X.2012.11331.x.
    Full Text Link to Item
  - Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Prostate cancer treatment unblinded.” Lancet Oncol, June 2012. https://doi.org/10.1016/S1470-2045(12)70136-5.
    Full Text Link to Item
- Conference Papers
  - Vigneswaran, Hari, Luke Mittelstaedt, Alessio Crippa, Martin Eklund, Adriana Vidal, Stephen Freedland, and Michael Abern. “PROGRESSION ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER IN BLACK MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS.” In Journal of Urology, 206:E565–66, 2021.
    Link to Item
  - Gagnon-Konamna, M., M. Krajmerova, C. Donahue, J. Sugrue, A. Abcarian, M. Abern, J. Harrison, and V. Chaudhry. “MANAGEMENT OF COLOVESICAL FISTULAS - IS THERE A COMMON PRACTICE?” In Diseases of the Colon & Rectum, Vol. 64, 2021.
    Link to Item
  - Zakharia, Yousef, Eric A. Singer, Ryan Ross, Monika Joshi, Michael Abern, Rohan Garje, Joseph J. Park, Ilona Kryczek, Weiping Zou, and Ajjai Shivaram Alva. “Phase Ib/II study of durvalumab and guadecitabine in advanced kidney cancer Big Ten Cancer Research Consortium BTCRC GU16-043.” In Journal of Clinical Oncology, 39:328–328. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.6_suppl.328.
    Full Text
  - Nguyen, N., K. Rugen, D. Moreira, O. Acar, M. Abern, S. Crivellaro, and E. Kocjancic. “FACTORS INFLUENCING NONCOMPLIANCE WITH PELVIC FLOOR MUSCLE EXERCISES IN THE MANAGEMENT OF URINARY INCONTINENCE FOLLOWING ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY.” In Neurourology and Urodynamics, 39:S42–44, 2020.
    Link to Item
  - Carbunaru, Samuel, Oluwarotimi Nettey, Edward M. Schaeffer, Peter H. Gann, Michael Abern, Courtney M. P. Hollowell, Karriem Watson, Tiffany McDowell, Rick A. Kittles, and Adam B. Murphy. “Abstract A066: Performance of the prostate health index (PHI) assay in black men.” In Poster Presentations Proffered Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7755.disp19-a066.
    Full Text
  - Murphy, Adam B., Samuel Carbunaru, Michael Abern, Courtney M. P. Hollowell, Roohollah Sharifi, and Peter H. Gann. “Abstract A082: ENACT: A randomized trial assessing the impact of the Oncotype DX Prostate Cancer Assay on treatment decision in a racially diverse population of men eligible for active surveillance.” In Poster Presentations Proffered Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7755.disp19-a082.
    Full Text
  - Madueke, Ikenna, Wen-Yang Hu, Lishi Xie, Donald Vander Griend, Michael Abern, and Gail Prins. “SPINK1 IS ASSOCIATED WITH CASTRATION RESISTANCE IN PROSTATE CANCER.” In Journal of Urology, 203:E770–E770, 2020.
    Link to Item
  - Naha, Ushasi, Michael Abern, and Daniel Moreira. “THE ASSOCIATION OF CANCER SPECIFIC ANXIETY WITH DISEASE AGGRESSIVENESS IN MEN ON ACTIVE SURVEILLANCE OF PROSTATE CANCER.” In Journal of Urology, 203:E340–41, 2020.
    Link to Item
  - Vigneswaran, Hari T., Andrea Discacciati, Peter Gann, Henrik Gronberg, Martin Eklund, and Michael R. Abern. “ETHNIC VARIATION IN PROSTATE CANCER DETECTION: A HYPOTHESIS GENERATING STUDY FOR USE OF THE STOCKHOLM3 TEST IN AN AMERICAN COHORT.” In Journal of Urology, 203:E1148–E1148, 2020.
    Link to Item
  - Madueke, Ikenna, Wen-Yang Hu, Danping Hu, Michael Abern, and Gail Prins. “SIGNIFICANCE OF CANONICAL WNT10B IN PROSTATE GLAND DEVELOPMENT AND CARCINOGENESIS.” In Journal of Urology, 201:E977–78, 2019.
    Link to Item
  - Schwarzman, Logan, Rodrigo Pagani, Samuel Ohlander, Michael Abern, Gerald Andriole, Stephen Freedland, and Daniel Moreira. “DIAGNOSTIC PROPERTIES OF PROSTATE-SPECIFIC ANTIGEN TO PREDICT PROSTATE CANCER AND CLINICALLY SIGNIFICANT PROSTATE CANCER AMONG MEN WITH ANDROGEN DEFICIENCY.” In Journal of Urology, 201:E652–E652, 2019.
    Link to Item
  - Vigneswaran, Hari T., Meltem Uyanik, Rolf Reiter, Virgilia Macias, Winnie Mar, Karen L. Xie, Richard L. Magin, and Michael R. Abern. “IMPROVED ACCURACY OF MRI/US FUSION PROSTATE BIOPSY USING A STRETCHED EXPONENTIAL DIFFUSION PARAMETER.” In Journal of Urology, 201:E1079–E1079, 2019.
    Link to Item
  - Vijayakumar, Vish, Jyotsna S. Jagai, Michael R. Abern, and Andre Kajdacsy-Balla. “Association between cadmium Air Exposure and Prostrate Cancer Stage at Diagnosis.” In Faseb Journal, Vol. 33, 2019.
    Link to Item
  - Zenner, Morgan, Michael Abern, Ruben Sauer, Gayatry Mohapatra, Klara Valyi-Nagy, and Larisa Nonn. “THE POTENTIAL FOR CIRCULATING EXTRACELLULAR VESICLE MICRORNAS TO PREDICT PROSTATE CANCER AGGRESSIVENESS.” In Journal of Urology, 201:E341–42, 2019.
    Link to Item
  - Greenwald, David T., Jyotsna S. Jagai, Achal P. Patel, Daniel M. Moreira, and Michael R. Abern. “ASSOCIATION BETWEEN ENVIRONMENTAL QUALITY AND PROSTATE CANCER STAGE AT DIAGNOSIS.” In Journal of Urology, 199:E264–E264, 2018.
    Link to Item
  - Nettey, Oluwarotimi, Austin Walker, Mary Kate Keeter, Aishwarya Nugooru, Iman Martin, Maria Ruden, Pooja Gogana, et al. “BLACK RACE PREDICTS SIGNIFICANT PROSTATE CANCER INDEPENDENT OF CLINICAL SETTING, AND CLINICAL AND SOCIOECONOMIC RISK FACTORS: EVIDENCE FOR A BIOLOGICAL BASIS OF DISPARITIES.” In Journal of Urology, 199:E269–E269, 2018.
    Link to Item
  - Wilson, Nathaniel, Dimitri Papagiannopoulos, Nicholas O’Block, Michael Abern, Lester Raff, Christopher Coogan, and Kalyan Latchamsetty. “MP11-15 PREDICTORS OF FLUOROQUINOLONE RESISTANCE IN THE RECTAL VAULT OF MEN UNDERGOING PROSTATE BIOPSY.” In Journal of Urology, Vol. 197. Ovid Technologies (Wolters Kluwer Health), 2017. https://doi.org/10.1016/j.juro.2017.02.416.
    Full Text
  - Abhyankar, N., O. Shoshany, M. Kathrins, M. Abern, and C. Niederberger. “A safety study of clomiphene citrate; evaluating its effects on PSA, hemoglobin and estradiol.” In Fertility and Sterility, 106:e238–39. Elsevier BV, 2016. https://doi.org/10.1016/j.fertnstert.2016.07.686.
    Full Text
  - Abhyankar, Nikita, Kent Hoskins, Michael Abern, and Gregory Calip. “PD09-08 SHOULD A MAN WITH A HISTORY OF BREAST CANCER BE SCREENED FOR PROSTATE CANCER?” In Journal of Urology, Vol. 195. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.1016/j.juro.2016.02.2903.
    Full Text
  - Longo, Thomas, Ajay Gopalakrishna, Joseph Fantony, Richmond Owusu, Raymond Lance, Wen-Chi Foo, Brant Inman, and Michael Abern. “MP01-09 CAN A GENE METHYLATION ASSAY IMPROVE THE PERFORMANCE OF CYTOLOGY?” In Journal of Urology, Vol. 195. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.1016/j.juro.2016.02.1839.
    Full Text
  - Ovadia, Aaron E., Martha K. Terris, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Stephen J. Freedland, and Michael R. Abern. “Agent Orange and long-term outcomes after radical prostatectomy.” In Urol Oncol, 33:329.e1-329.e6, 2015. https://doi.org/10.1016/j.urolonc.2015.04.012.
    Full Text Link to Item
  - Al Rasheed, M Haroon, S. Setty, A. Dudek, and M. Abern. “FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND PAPILLARY RENAL CELL CARCINOMA: CAUSAL LINK?” In Journal of Investigative Medicine, 63:693–693, 2015.
    Link to Item
  - Mendez, Melissa, Mitchell Bassett, Michael Abern, Lionel Banez, Michael Ferrandino, Cary Robertson, Stephen Freedland, et al. “MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.875.
    Full Text
  - Tsivian, Matvey, Melissa Mendez, Michael Abern, Peter Qi, Edward Rampersaud, and Thomas Polascik. “MP59-01 IMPACT OF BLOOD TRANSFUSIONS ON ONCOLOGICAL OUTCOMES OF SURGICALLY TREATED LOCALIZED RENAL CELL CARCINOMA.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.2161.
    Full Text
  - Wadhwa, Harpreet, Martha Terris, William Aronson, Christopher Kane, Christopher Amling, Matthew Cooperberg, Stephen Freedland, and Michael Abern. “MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT.” In Journal of Urology, Vol. 193. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1016/j.juro.2015.02.1706.
    Full Text
  - Sun, B., E. L. Wiley, S. Garzon, S. Setty, M. Abern, N. Malhotra, and J. Bui. “CYSTIC NEPHROMA: A BENIGN TUMOR OR HAMARTOMATOUS PROLIFERATION?” In Journal of Investigative Medicine, 62:741–741, 2014.
    Link to Item
  - Abern, Michael, Zeljko Vujaskovic, Mark W. Dewhirst, Lan Lan, Oana I. Craciunescu, Paul Stauffer, and Brant Allen Inman. “Phase I clinical trial of external hyperthermia and intravesical mitomycin C to treat BCG-refractory bladder cancer.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Abern, Michael, William Aronson, Martha Terris, Christopher Kane, Christopher Amling, Matthew Cooperberg, and Stephen Freedland. “1497 OVERSTAGING HIGH-RISK PROSTATE CANCER MAY LEAD TO OVERTREATMENT: RESULTS FROM THE SEARCH DATABASE.” In Journal of Urology, Vol. 189. Ovid Technologies (Wolters Kluwer Health), 2013. https://doi.org/10.1016/j.juro.2013.02.2976.
    Full Text
  - McNamara, Erin, Michael Abern, Megan McPhail, Robert Kundich, Leah Gerber, Katharine Sourbeer, Devon Beverly, Lee Jones, and Stephen Freedland. “1521 EXERCISE PROTECTS AGAINST SEXUAL DYSFUNCTION IN A COHORT OF MIDDLE-AGED MEN.” In Journal of Urology, Vol. 189. Ovid Technologies (Wolters Kluwer Health), 2013. https://doi.org/10.1016/j.juro.2013.02.2999.
    Full Text
  - Tsivian, Matvey, Michael Abern, Peter Qi, John Yoo, Paul Evans, Charles Kim, Thomas Polascik, and Michael Ferrandino. “1799 RADIATION EXPOSURE FROM RENAL MASS PROTOCOL CT: WHAT IS THE IMPACT OF BODY HABITUS?” In Journal of Urology, Vol. 189. Ovid Technologies (Wolters Kluwer Health), 2013. https://doi.org/10.1016/j.juro.2013.02.2849.
    Full Text
  - Masko, Elizabeth M., Michael E. Lipkin, Michael R. Abern, Emma H. Allott, Alexis R. Gaines, Jonathan C. Routh, John S. Wiener, Glenn M. Preminger, and Sherry S. Ross. “EFFECTS OF SODIUM AND FRUCTOSE INTAKE ON PEDIATRIC STONE FORMATION.” In Journal of Endourology, 26:A111–A111. MARY ANN LIEBERT INC, 2012.
    Link to Item
  - Bassett, Mitchell, Michael Abern, Lionel Lloyds Banez, Michael Ferrandino, Cary N. Robertson, Brant Allen Inman, Thomas Polascik, Stephen J. Freedland, Philip John Walther, and Judd W. Moul. “African American race to predict for earlier failure of active surveillance: Results from the Duke Prostate Center.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
    Link to Item
  - Abern, Michael R., Elizabeth M. Masko, Chenwei Wu, Alexis R. Gaines, Salvatore Pizzo, and Stephen J. Freedland. “Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model.” In Experimental and Molecular Therapeutics. American Association for Cancer Research, 2012. https://doi.org/10.1158/1538-7445.am2012-5631.
    Full Text
  - Allott, Emma H., Xiaohu Tang, Elizabeth M. Masko, Alexis Gaines, Michael R. Abern, Jen-Tsan A. Chi, and Stephen J. Freedland. “Abstract 5255: Methionine restriction limits prostate tumor cell proliferation.” In Tumor Biology. American Association for Cancer Research, 2012. https://doi.org/10.1158/1538-7445.am2012-5255.
    Full Text
  - Abern, Michael, Elizabeth Masko, Chenwei Wu, Alexis Gaines, Salvatore Pizzo, and Stephen Freedland. “1322 THE EFFECT OF POMEGRANATE EXTRACT DOSE ON PROSTATE CANCER GROWTH IN A CARBOHYDRATE RESTRICTED MOUSE XENOGRAFT MODEL.” In Journal of Urology, Vol. 187. Ovid Technologies (Wolters Kluwer Health), 2012. https://doi.org/10.1016/j.juro.2012.02.1669.
    Full Text
  - Abern, Michael, Stephen Freedland, William Aronson, Martha Terris, Joseph Presti, Christopher Kane, and Christopher Amling. “997 DELAYED RADICAL PROSTATECTOMY IN GLEASON 7 PROSTATE CANCER DECREASES TIME TO BIOCHEMICAL RECURRENCE: RESULTS FROM THE SEARCH DATABASE.” In Journal of Urology, Vol. 187. Ovid Technologies (Wolters Kluwer Health), 2012. https://doi.org/10.1016/j.juro.2012.02.1098.
    Full Text
  - Abern, Michael, Ann Dude, Kalyan Latchamsetty, and Christopher Coogan. “162 SALVAGE RADICAL PROSTATECTOMY AFTER RADIATION THERAPY.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.230.
    Full Text
  - Abern, Michael, Ann Dude, and Christopher Coogan. “468 SECONDARY BLADDER CANCER AFTER RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.561.
    Full Text
  - Abern, M., L. Levine, J. A. Hyun, and S. C. Kam. “PENILE TRACTION THERAPY ADDED TO INTRALESIONAL VERAPAMIL INJECTIONS FOR PEYRONIE'S DISEASE.” In Journal of Sexual Medicine, 7:195–195, 2010.
    Link to Item
  - Taylor, Frederick, Michael Abern, and Laurence Levine. “650 PREDICTING ERECTILE DYSFUNCTION FOLLOWING SURGICAL CORRECTION OF PEYRONIE'S DISEASE WITHOUT INFLATABLE PENILE PROSTHESIS PLACEMENT: VASCULAR ASSESSMENT AND PREOPERATIVE RISK FACTORS.” In Journal of Urology, Vol. 183. Ovid Technologies (Wolters Kluwer Health), 2010. https://doi.org/10.1016/j.juro.2010.02.1024.
    Full Text
  - Taylor, Frederick, Michael Abern, and Laurence Levine. “PREDICTING ERECTILE DYSFUNCTION FOLLOWING SURGICAL CORRECTION OF PEYRONIE'S DISEASE WITHOUT INFLATABLE PENILE PROSTHESIS PLACEMENT: VASCULAR ASSESSMENT AND PREOPERATIVE RISK FACTORS.” In Journal of Sexual Medicine, 7:12–12, 2010.
    Link to Item
  - Abern, Michael R., Kalyan Latchamsetty, Christopher Boniquit, Jerome Hoeksema, and Christopher L. Coogan. “PSA DENSITY PREDICTS PATHOLOGIC UPSTAGING AFTER RADICAL PROSTATECTOMY.” In Journal of Urology, 181:104–5. Ovid Technologies (Wolters Kluwer Health), 2009. https://doi.org/10.1016/s0022-5347(09)60299-8.
    Full Text
  - Levine, Laurence A., and Michael R. Abern. “Intralesional verapamil injections with and without vacuum therapy for management of Peyronie's disease.” In Journal of Sexual Medicine, 5:38–38, 2008.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Subject Headings

Selected Grants

External Relationships

Selected Publications

Academic Articles

Book Sections

Other Articles

Conference Papers